Cite

HARVARD Citation

    Zammarchi, F. et al. (n.d.). ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers. European journal of cancer. pp. S28-. [Online]. 
  
Back to record